Search Result "World Health Organization Classification of AML"
World Health Organization Classification of Myelodysplastic Syndromes
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3149-3162
Author(s): Magdalena Czader,Attilio Orazi
The Evolving AML Genomic Landscape: Therapeutic Implications
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 7 Year: 2020 Page: 532-544
Author(s): Sachi Horibata,George Alyateem,Christin B. DeStefano,Michael M. Gottesman
Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 29 Year: 2017 Page: 4303-4310
Author(s): Yuan Ling,Zikang Zhang,Hua Zhang,Zunnan Huang
Proteomics in Acute Myelogenous Leukaemia (AML): Methodological Strategies and Identification of Protein Targets for Novel Antileukaemic Therapy
Journal: Current Drug Targets
Volume: 6 Issue: 6 Year: 2005 Page: 631-646
Author(s): G. Sjoholt, N. Anensen, L. Wergeland, E. Mc Cormack, O. Bruserud, B. T. Gjertsen
The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia
Journal: Current Pharmaceutical Biotechnology
Volume: 17 Issue: 1 Year: 2016 Page: 6-19
Author(s): Rakel B. Forthun,Carina Hinrichs,Tara H. Dowling,Ãystein Bruserud,Frode Selheim
Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 18 Issue: 3 Year: 2018 Page: 199-207
Author(s): Elumalai Suguna,Rahman Farhana,Elangovan Kanimozhi,Pindigiri Sai Kumar,Govindasamy Kumaramanickavel,Chitralekha Sai Kumar
Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients
Journal: Current Pharmaceutical Biotechnology
Volume: 17 Issue: 1 Year: 2016 Page: 52-70
Author(s): Elise Aasebø,Rakel B. Forthun,Frode Berven,Frode Selheim,Maria Hernandez-Valladares
Implications of Somatic Mutations in the AML1/RUNX1 Gene in Myelodysplastic Syndrome (MDS): Future Molecular Therapeutic Directions for MDS
Journal: Current Cancer Drug Targets
Volume: 6 Issue: 6 Year: 2006 Page: 553-563
Author(s): Hironori Harada, Yuka Harada, Akiro Kimura
Xenograft models of primary acute myeloid leukemia for the development of imaging strategies and evaluation of novel targeted therapies.
Journal: Current Pharmaceutical Biotechnology
Volume: 17 Issue: 1 Year: 2016 Page: 42-51
Author(s): Pascal Gelebart,Mihaela Popa,Emmet McCormack
Pediatric Health Effects of Chronic Exposure to Extremely Low Frequency Electromagnetic Fields
Journal: Current Pediatric Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 234-240
Author(s): Juan Antonio Ortega-Garcia, Marlene Martin, Enrique Navarro-Camba, Julia Garcia-Castell, Offie P. Soldin, Josep Ferris-Tortajada